IT is estimated that just 5,000 US pharmacies offer point-of-care (POC) molecular diagnostics with the other 83,000 locations only offering sample collection / send out services or providing no…
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50122C00078
- Awardee
-
Diasorin Molecular, LLC UEI KFFNMC55GHS5
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $30,954,000
Award facts
- Opportunity
-
- BAA18SOL00003 Solicitation number
- Contract value 100% obligated
- $30,954,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Cypress, CA 90630, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $30,954,000 |
About this award
This federal contract award, valued at $30,954,000.00, was made by the Office of the Assistant Secretary for Preparedness and Response to Diasorin Molecular, LLC, a foreign-owned, for-profit medical diagnostics manufacturer based in Cypress, California. The contract is a definitive, firm-fixed-price agreement with a period of performance extending through June 30, 2026.
The purpose of this contract is to expand the availability of point-of-care molecular diagnostics in U.S. pharmacies. Diasorin Molecular will provide specialized diagnostic products and services, including testing reagents, analyzers, and polymerase chain reaction instrumentation, to support the federal government's healthcare response efforts. This contract does not have a set-aside designation. Diasorin Molecular has previously secured several Indefinite Delivery Vehicles with the Department of Veterans Affairs to supply COVID-19, influenza, and other infectious disease testing capabilities to VA medical centers.
Description
IT is estimated that just 5,000 US pharmacies offer point-of-care (POC) molecular diagnostics with the other 83,000 locations only offering sample collection / send out services or providing no testing at all. In this effort, luminex corporation, a
Quick answers
Who was awarded contract 75A50122C00078?
75A50122C00078 was awarded to Diasorin Molecular, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2022.
How much is contract 75A50122C00078 worth?
The government has obligated $30,954,000 on 75A50122C00078.
Was contract 75A50122C00078 competed?
The extent of competition for 75A50122C00078 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award